Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
The American heart journal, 2011-12, Vol.162 (6), p.966-972.e10 [Peer Reviewed Journal]Mosby, Inc. ;2011 Mosby, Inc. ;2015 INIST-CNRS ;Copyright © 2011 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Dec 2011 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2011.09.007 ;PMID: 22137068 ;CODEN: AHJOA2
Full text available